The Role of Probiotics in Colorectal Cancer Management
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Colorectal cancer (CRC) is one of the most common cancerous diseases worldwide and causes leading cancer‐associated deaths. Several factors are related to the incidence of CRC such as unhealthy diet and lifestyle, heredity, metabolic disorders, and genetic factors. Even though several advanced medical procedures are available for CRC treatment, the survival rates are poor with many adverse treatments associated side effects, which affects the quality of life. Probiotics are a well‐known bioactive candidate for the treatment of several diseases and ill‐health conditions. The recent scientific evidence suggested that probiotic supplementation protects the CRC patients from treatment‐associated adverse effects. The manuscript summarizes the influence of probiotic supplementation on the health status of CRC patients and discusses the possible mechanism behind the protective effect of probiotics against CRC. The literature survey revealed that beneficial impact of probiotic supplementation depends on several factors such as strain, dosage, duration of the intervention, host physiology, and other food supplements. The probiotic intervention improves the microbiota, releases antimicrobials and anticarcinogenic agents, helps to remove carcinogens, and improves the intestinal permeability, tight junction function, and enzyme activity in CRC patients. Besides, not all probiotic strains exhibit anti‐CRC activities; it is necessary to screen the potent strain for the development of a probiotic‐based therapeutic agent to control or prevent the incidence of CRC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Lenoir, M., del Carmen, S., Cortes-Perez, N. G., Lozano-Ojalvo, D., Muñoz-Provencio, D., Chain, F., Langella, P., de Moreno de LeBlanc, A., LeBlanc, J. G., & Bermúdez-Humarán, L. G. (2016) · Journal of Gastroenterology · doi:10.1007/s00535-015-1158-9 · Cited by 155 · cited 11×
“casei BL23 (10 μl; 1× 10 8 CFU/μl) 3 days (on days 0, 14, 28) ↓ incidence of tumor ↓ multiple plaque lesions Regulates the Treg and )17 T cells Altered the expression of IL-6, IL-10, IL-17, and TGF-β [45]”
BackgroundInfluentialRetractedIntestinal inflammation targets cancer-inducing activity of the microbiota
Arthur, J. C., Perez-Chanona, E., Mühlbauer, M., Tomkovich, S., Uronis, J. M., Fan, T.-J., Campbell, B. J., Abujamel, T., Dogan, B., Rogers, A. B., et al. (2012) · Science · doi:10.1126/science.1224820 · Cited by 2,263
Terzić, J., Grivennikov, S., Karin, E., & Karin, M. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.058 · Cited by 1,974
A bacterial driver–passenger model for colorectal cancer: beyond the usual suspects
Tjalsma, H., Boleij, A., Marchesi, J. R., & Dutilh, B. E. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2819 · Cited by 903 · cited 2×
“)e chronic inflammation is one of the lethal factors associated with the development of CRC, which disturb the intestinal microbiota [77, 84].”
BackgroundKarczewski, J., Troost, F. J., Konings, I., Dekker, J., Kleerebezem, M., Brummer, R.-J. M., & Wells, J. M. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00327.2009 · Cited by 676
Hibberd, A. A., Lyra, A., Ouwehand, A. C., Rolny, P., Lindegren, H., Cedgård, L., & Wettergren, Y. (2017) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2017-000145 · Cited by 373
Gamallat, Y., Meyiah, A., Kuugbee, E. D., Hago, A. M., Chiwala, G., Awadasseid, A., Bamba, D., Zhang, X., Shang, X., Luo, F., et al. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.07.001 · Cited by 232
Gianotti, L. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i2.167 · Cited by 209 · cited 2×
“[58] conducted a double-blind randomized controlled trial to study the effect of probiotics (B.”
BackgroundBaldwin∗, C., Millette∗, M., Oth †, D., Ruiz, M. T., Luquet, F.-M., & Lacroix, M. (2010) · Nutrition and Cancer · doi:10.1080/01635580903407197 · Cited by 170 · cited 3×
“[22] demonstrated the effect of live or inactive probiotic strains (different concentrations of Lactobacillus acidophilus, and L.”
BackgroundInfluentialHu, J., Wang, C., Ye, L., Yang, W., Huang, H., Meng, F., Shi, S., & Ding, Z. (2015) · Journal of Biosciences · doi:10.1007/s12038-015-9518-4 · Cited by 124 · cited 3×
“rhamnosus; 1× 10(9) CFU/day Pre-exposure for 14 days ↓ CT26 growth ↑ lifespan of tumor-bearing mice ↑ IFN-c, )1-type CD4 T differentiation ↑ CD8 function ↑ NK cell infiltration [42] Evidence-Based Complementary and Alternative Medicine 7”
BackgroundInfluential
Cited by
Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease
Kesika, P., Suganthy, N., Sivamaruthi, B. S., & Chaiyasut, C. (2021) · Life Sciences · doi:10.1016/j.lfs.2020.118627 · Cited by 479
Self-citationAzwar, S., Seow, H. F., Abdullah, M., Faisal Jabar, M., & Mohtarrudin, N. (2021) · Biology · doi:10.3390/biology10090854 · Cited by 173
Tajasuwan, L., Kettawan, A., Rungruang, T., Wunjuntuk, K., & Prombutara, P. (2023) · Nutrients · doi:10.3390/nu15061528 · Cited by 49
Unveiling The Therapeutic Potential of Probiotics: A Review
Tukaram, K. S., Sopanrao, S. R., & Kacharu, L. O. (2025) · Journal of Future Foods · doi:10.1016/j.jfutfo.2025.09.011 · Cited by 19
Wang, X., Huang, Y., Yang, Z., Yang, Y., Wei, F., Yan, M., Li, F., & Wang, C. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-03604-9 · Cited by 18
Metadata
- Authors
- Sivamaruthi, B. S., Kesika, P., & Chaiyasut, C.
- Venue
- Evidence-Based Complementary and Alternative Medicine
- Publisher
- Wiley
- Published
- 2020-01
- Volume
- 2020
- Issue
- 1
- Pages
- 3535982-3535982
- ISSN
- 1741-427X (ISSN-L)
- 1741-4288
- OpenAlex
- W3005940526
- Cited by
- 118
- References
- 16
- FWCI
- 10.29
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.